GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (XTER:FYB) » Definitions » Short-Term Capital Lease Obligation

Formycon AG (XTER:FYB) Short-Term Capital Lease Obligation : €1.23 Mil (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Formycon AG Short-Term Capital Lease Obligation?

Formycon AG's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2024 was €1.23 Mil.

Formycon AG's quarterly Short-Term Capital Lease Obligation increased from Jun. 2023 (€1.09 Mil) to Dec. 2023 (€1.19 Mil) and increased from Dec. 2023 (€1.19 Mil) to Jun. 2024 (€1.23 Mil).

Formycon AG's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€0.88 Mil) to Dec. 2022 (€0.93 Mil) and increased from Dec. 2022 (€0.93 Mil) to Dec. 2023 (€1.19 Mil).

Formycon AG Short-Term Capital Lease Obligation Historical Data

The historical data trend for Formycon AG's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formycon AG Short-Term Capital Lease Obligation Chart

Formycon AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.88 0.93 1.19

Formycon AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.96 0.93 1.09 1.19 1.23

Formycon AG Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Formycon AG Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Formycon AG's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Formycon AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (XTER:FYB) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
XTER:MOR XTER:BIO XTER:HPHA XTER:BNN XTER:MDG1 XTER:T5O OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB
Traded in Other Exchanges
0W4N:UK
Address
Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Website
https://www.formycon.com
Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID-19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.
Executives
Dr. Nicola Mikulcik Board of Directors
Dr. Stefan Glombitza Board of Directors
Dr. Carsten Brockmeyer Board of Directors
Dr. Nicolas Combé Board of Directors

Formycon AG Headlines

No Headlines